A study published in JAMA Network Open revealed that for men with N1 prostate cancer undergoing external beam radiation therapy (EBRT) with concomitant androgen deprivation therapy (ADT), treatment at a facility with high radiation case volume, regardless of academic affiliation, was correlated with longer overall survival (OS).
“Numerous studies have shown that patients with cancer who are treated at high-volume facilities have higher rates of long-term survival, including those who undergo primary surgery, radiation, or chemotherapy,” wrote the study authors, led by Sagar A. Patel, MD. “Given the complexity of management of N1 prostate cancer, we hypothesized that men treated at high-volume centers would have improved OS compared with those treated at low-volume centers.”
To evaluate the association between radiation facility case volume and OS among men with N1 prostate…
